Aerovate Therapeutics, Inc.

Historical 13F Holders

Symbol
AVTE
CUSIP
008064107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 87 31.7 M $79.6 M
2024 Q4 86 30.2 M $79.9 M
2024 Q3 81 27.7 M $57.8 M
2024 Q2 99 27.2 M $45.2 M
2024 Q1 85 28.5 M $843 M
2023 Q4 68 28.3 M $641 M
2023 Q3 60 28.5 M $386 M
2023 Q2 61 28.5 M $488 M
2023 Q1 68 26.0 M $524 M
2022 Q4 72 27.6 M $809 M
2022 Q3 57 27.0 M $447 M
2022 Q2 52 25.8 M $403 M
2022 Q1 47 25.9 M $475 M
2021 Q4 49 25.6 M $302 M
2021 Q3 42 21.7 M $453 M
2021 Q2 19 20.0 M $454 M